• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Home | Protein Kinase Inhibitors

Protein Kinase Inhibitors

 

A protein kinase inhibitor is an enzyme inhibitor that blocks the action of protein kinases. Protein kinases are important regulators of cell functions that utilize a process known as phosphorylation. In phosphorylation, phosphate groups are added to specific binding sites on other proteins resulting in a physical conformational change that can turn on or off the activity of the molecule.

This simple addition or subtraction of phosphate groups has an enormous impact on the activity in the cell. Protein kinases are responsible for regulating signal transduction, the cell cycle, proliferation, metabolism, and apoptosis. Because they are so integral to so many key cell functions, a disease like cancer (characterized by abnormal cell growth) relies heavily on protein kinases to survive and spread. Inhibition of this phosphate binding action has become a promising research area for cancer therapies.

LKT Laboratories carries hundreds of protein kinase inhibitors for use in the research of protein and cell functions, especially as they pertain to cancer, autoimmune disorders, cardiac disease, and other conditions.

Inhibitors By Binding Site

Protein kinase inhibitors are typically categorized by the amino acid they act on. Tyrosine, serine, and threonine are all possible binding locations for phosphate groups, and therefore possible targets for inhibition.

Tyrosine Kinase Inhibitors                                   Serine/Threonine Kinase Inhibitors

Inhibitors By Pathway

LKT’s broad selection of inhibitors target many different signaling pathways. These pathways are frequently involved with cellular proliferation and growth, so it’s not surprising that they are being studied in cancer research. Some of the most popular signaling pathway targets include:

Abl          Akt          ALK          AMPK          CDK          c-met          EGFR          ERK

GSK3          JAK          JNK          MEK          mTOR          PI3K          Raf           VEGFR

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only